IPO Listed — 20 Aug 2026
Listing Price: ₹359.1
Credent Connect N Care SME IPO GMP History | Listing Price ₹359.1 & Kostak Rate
Credent Connect N Care SME IPO has been listed on August 20, 2026 at a listing price of ₹359.1, against the issue price of ₹189 — a gain of ₹170.1 (+90%). The GMP peaked at ₹92 on 20 August 2026 and reached a low of ₹35 on 11 August 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Credent Connect N Care SME IPO raised ₹93.9 Cr. through its IPO at a price band of ₹179 to ₹189 per share, with a lot size of 600 shares. The IPO was open for subscription from 13 Aug 2026 to 17 Aug 2026.
GMP Trend Chart
Day-wise GMP Trend
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 20 Aug 2026 | ₹ 92 | 48.68% | ₹ 0 | ₹ 0 | |
| 19 Aug 2026 | ₹ 91 | 48.15% | ₹ 0 | ₹ 0 | |
| 18 Aug 2026 | ₹ 63 | 33.33% | ₹ 0 | ₹ 0 | |
| 17 Aug 2026 | ₹ 45 | 23.81% | ₹ 0 | ₹ 0 | |
| 16 Aug 2026 | ₹ 55 | 29.10% | ₹ 0 | ₹ 0 | |
| 15 Aug 2026 | ₹ 55 | 29.10% | ₹ 0 | ₹ 0 | |
| 14 Aug 2026 | ₹ 65 | 34.39% | ₹ 0 | ₹ 0 | |
| 13 Aug 2026 | ₹ 75 | 39.68% | ₹ 0 | ₹ 0 | |
| 12 Aug 2026 | ₹ 50 | 26.46% | ₹ 0 | ₹ 0 | |
| 11 Aug 2026 | ₹ 35 | 18.52% | ₹ 0 | ₹ 0 |
Credent Connect N Care SME IPO Dates
| Event | Date |
|---|---|
| Open Date | 13 Aug, 2026 |
| Close Date | 17 Aug, 2026 |
| Allotment Date | 18 Aug, 2026 |
| Refund Date | 19 Aug, 2026 |
| Credit to Demat | 19 Aug, 2026 |
| Listing Date | 20 Aug, 2026 |
Credent Connect N Care SME IPO Actual Listing Price
| Basis | Value |
|---|---|
| Issue Price | ₹189 |
| GMP-Based Estimate (Pre-Listing) | ₹281 (+48.7%) |
| Actual Listing Price | ₹359.1 (+90%) |
| Listing Gain / Loss | +₹170.1 per share |
| Listing Date | 20 Aug, 2026 |
Is Credent Connect N Care SME IPO GMP Reliable?
Grey market premium for Credent Connect N Care SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- Cross-check before acting: Review the Credent Connect N Care SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Credent Connect N Care SME IPO IPO Kostak Rate Explained
The Kostak rate for Credent Connect N Care SME IPO was not active during the subscription period, as no grey market premium was established. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not active for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Credent Connect N Care SME IPO
Its services include home sample collection through trained phlebotomists, supplying laboratory and phlebotomy manpower to hospitals, diagnostic and paramedical services, healthcare logistics, and corporate wellness programmes. Its logistics work covers movement of test samples, medical supplies and reagents in temperature controlled and time bound conditions, including cold chain transport. It also runs a courier aggregation platform called C3 Post and a corporate wellness business under the C3 Wellness brand which does health camps, vaccination drives and preventive health check ups.
The company works across India through warehouses, branch offices, its own vehicles and field staff. It has grown partly through acquisitions, including Credent Healthcare Private Limited, Credent Team Private Limited and Alltrak Technologies Private Limited. It holds ISO 9001:2015 and ISO 15189:2022 certification. As on 31 March 2026 it had 6,338 people working with it, of which 4,052 were on its payroll and 2,286 were on contract.
Strengths & Risks
Strengths
- ✓ The company offers logistics, manpower, diagnostics support and wellness services together, so a hospital or lab can get several needs met from one vendor.
- ✓ It works pan India through warehouses, branch offices, its own vehicles and field staff, which is difficult for a new competitor to build quickly.
- ✓ Cold chain and time bound transport of test samples is a specialised job and needs proper systems, which acts as an entry barrier.
- ✓ The B2B model with laboratories and hospitals gives repeat and contract based business rather than one time sales.
- ✓ It has built technology platforms of its own such as C3 Post for courier aggregation and C3 HRMS for managing its large workforce.
- ✓ The company holds ISO 9001:2015 and ISO 15189:2022 certification, the second one being specific to medical laboratories.
- ✓ Net worth improved from Rs 13.66 crore to Rs 15.90 crore and EBITDA from Rs 4.30 crore to Rs 4.99 crore between FY2024 and FY2025.
- ✓ Rs 29.80 crore of the issue money goes into its wholly owned subsidiary Credent Healthcare for working capital and machinery.
Risks
- ⚠ Profit fell in the latest year shown in the offer document. Profit after tax came down from Rs 2.66 crore in FY2024 to Rs 2.25 crore in FY2025, even though income rose slightly from Rs 76.02 crore to Rs 78.23 crore.
- ⚠ The margin is very thin. Profit after tax of Rs 2.25 crore on total income of Rs 78.23 crore works out to under 3%.
- ⚠ The issue size of Rs 93.90 crore is large compared to the size of the business. Net worth was only Rs 15.90 crore and profit only Rs 2.25 crore as on 31 March 2025.
- ⚠ This is a people heavy business. It runs with 6,338 workers for about Rs 78 crore of income, so any rise in wages directly eats into the small margin.
- ⚠ More than a third of the workforce, 2,286 out of 6,338, is on contract, which brings attrition and compliance risk.
- ⚠ The company has grown through acquisitions of three companies. Merging different businesses does not always work out as planned.
- ⚠ Rs 37.00 crore of the money is for its own working capital, which shows that a lot of money stays blocked in receivables from hospitals and labs.
- ⚠ This is an SME issue. One lot is 600 shares, which is about Rs 1.13 lakh at the upper band of Rs 189, and SME shares usually trade in low volume after listing.
Frequently Asked Questions about Credent Connect N Care SME IPO
What is the GMP of Credent Connect N Care SME IPO?
The current Grey Market Premium (GMP) of Credent Connect N Care SME IPO is ₹ 92.
What is the Kostak Price of Credent Connect N Care SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Credent Connect N Care SME IPO is currently not available.
What is the Subject to Sauda Price of Credent Connect N Care SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is currently not available.
What was the actual listing price of Credent Connect N Care SME IPO?
Credent Connect N Care SME IPO listed on August 20, 2026 at ₹359.1, against the issue price of ₹189 — a gain of +90%.
How did the GMP of Credent Connect N Care SME IPO trend before listing?
The GMP of Credent Connect N Care SME IPO was rising in its final days before listing. The GMP peaked at ₹92 on 20 August 2026. View the day-wise table above for the complete GMP history.
Explore Credent Connect N Care SME IPO Further
For a complete picture before making your investment decision, explore these resources:
